These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20023569)

  • 1. Ductal carcinoma in situ: size and resection volume predict margin status.
    Melstrom LG; Melstrom KA; Wang EC; Pilewskie M; Winchester DJ
    Am J Clin Oncol; 2010 Oct; 33(5):438-42. PubMed ID: 20023569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
    Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status, volume of resection, and pathologist workload.
    Rizzo M; Iyengar R; Gabram SG; Park J; Birdsong G; Chandler KL; Mosunjac MB
    Ann Surg Oncol; 2010 Jan; 17(1):228-34. PubMed ID: 19636625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
    Lagios MD; Silverstein MJ
    Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.
    MacDonald HR; Silverstein MJ; Mabry H; Moorthy B; Ye W; Epstein MS; Holmes D; Silberman H; Lagios M
    Am J Surg; 2005 Oct; 190(4):521-5. PubMed ID: 16164913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
    Vicini FA; Kestin LL; Goldstein NS
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J; Delaney G; Taylor R
    Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
    Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
    Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
    Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
    J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
    Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery.
    Huston TL; Pigalarga R; Osborne MP; Tousimis E
    Am J Surg; 2006 Oct; 192(4):509-12. PubMed ID: 16978962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
    Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
    Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
    Dunne C; Burke JP; Morrow M; Kell MR
    J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
    Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
    Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-menopausal Status, High Nuclear Grade, Tumor Size >30 mm and Positive Resection Margins Are Predictors of Residual Tumor After Lumpectomy for Ductal Carcinoma In Situ of the Breast.
    Joste M; Mendes V; Tixier S; Palpacuer C; Laviolle B; Leveque J; Ouldamer L
    Anticancer Res; 2015 Jun; 35(6):3471-7. PubMed ID: 26026112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.